With the analysis among 159 patents, we discovered top 30 key players by total patent application. Janssen Vaccines & Prevention BV, Cell Signaling Technology, Inc., Alnylam Pharmaceuticals, Inc. are dominant in this area. They take 51.57% of the total patent filing.
Janssen Vaccines & Prevention BV
Zuid-Holland, Netherlands
Patent: 39
Cell Signaling Technology, Inc.
Massachusetts, United States
Patent: 30
Alnylam Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 13
Accelerated Biosciences Corp.
Delaware, United States
Patent: 6
Eisai R&D Management Co., Ltd.
Incyte Pharmaceuticals, Inc.
California, United States
Patent: 5
New York, United States
Patent: 4
No data, please try another search term
With the analysis among related 69 patents applied in the last 5 years. We discover 20 most active companies in this area. The fast-growing Janssen Vaccines & Prevention BV, Alnylam Pharmaceuticals, Inc., Keio University take 60.87% of patent filing during this period.
Janssen Vaccines & Prevention BV
Zuid-Holland, Netherlands
Patent: 25
Alnylam Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 13
New Jersey, United States
Patent: 3
Centre National De La Recherche Scientif
Université de Montpellier I
Cell Signaling Technology, Inc.
Massachusetts, United States
Patent: 3
INSTITUTO DE MEDICINA MOLECULAR
Korea Institute of Science & Technology
With the analysis among related 69 patents in last 5 years, we discover 18 new entrants. Alnylam Pharmaceuticals, Inc., Keio University, PTC Therapeutics, Inc. are the most active new entrants in this area.
Alnylam Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 13
New Jersey, United States
Patent: 3
Centre National De La Recherche Scientif
Université de Montpellier I
INSTITUTO DE MEDICINA MOLECULAR
Korea Institute of Science & Technology
Shanghai Universal Biotech Co., Ltd.
Shanghai Shi, China
Patent: 1
The Board of Trustees of the University of Illinois
Illinois, United States
Patent: 1
With the analysis among 68 patents, we discovered top 17 universities and scientific research institutions by total patent application. Keio University, Nagoya University, The European Molecular Biology Laboratory are dominant in this area. They take 38.24% of the total patent filing.
Aichi-ken, Japan
Patent: 4
The European Molecular Biology Laboratory
Baden-Württemberg, Germany
Patent: 4
ZURICH, Switzerland
Patent: 2
The Trustees of Columbia University in The City of New York
New York, United States
Patent: 1
Council of Scientific & Industrial Research
Nordrhein-Westfalen, Germany
Patent: 1
Shanghai Shi, China
Patent: 1
Korea Institute of Science & Technology